Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells.

dc.contributor.author

Parker, Robert

dc.contributor.author

Partridge, Thomas

dc.contributor.author

Wormald, Catherine

dc.contributor.author

Kawahara, Rebeca

dc.contributor.author

Stalls, Victoria

dc.contributor.author

Aggelakopoulou, Maria

dc.contributor.author

Parker, Jimmy

dc.contributor.author

Powell Doherty, Rebecca

dc.contributor.author

Ariosa Morejon, Yoanna

dc.contributor.author

Lee, Esther

dc.contributor.author

Saunders, Kevin

dc.contributor.author

Haynes, Barton F

dc.contributor.author

Acharya, Priyamvada

dc.contributor.author

Thaysen-Andersen, Morten

dc.contributor.author

Borrow, Persephone

dc.contributor.author

Ternette, Nicola

dc.date.accessioned

2021-06-01T13:17:24Z

dc.date.available

2021-06-01T13:17:24Z

dc.date.issued

2021-05-13

dc.date.updated

2021-06-01T13:17:21Z

dc.description.abstract

Understanding and eliciting protective immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an urgent priority. To facilitate these objectives, we profile the repertoire of human leukocyte antigen class II (HLA-II)-bound peptides presented by HLA-DR diverse monocyte-derived dendritic cells pulsed with SARS-CoV-2 spike (S) protein. We identify 209 unique HLA-II-bound peptide sequences, many forming nested sets, which map to sites throughout S including glycosylated regions. Comparison of the glycosylation profile of the S protein to that of the HLA-II-bound S peptides reveals substantial trimming of glycan residues on the latter, likely induced during antigen processing. Our data also highlight the receptor-binding motif in S1 as a HLA-DR-binding peptide-rich region and identify S2-derived peptides with potential for targeting by cross-protective vaccine-elicited responses. Results from this study will aid analysis of CD4+ T cell responses in infected individuals and vaccine recipients and have application in next-generation vaccine design.

dc.identifier

S2211-1247(21)00524-6

dc.identifier.issn

2211-1247

dc.identifier.issn

2211-1247

dc.identifier.uri

https://hdl.handle.net/10161/23226

dc.language

eng

dc.publisher

Elsevier BV

dc.relation.ispartof

Cell reports

dc.relation.isversionof

10.1016/j.celrep.2021.109179

dc.subject

HLA class II

dc.subject

HLA-II

dc.subject

LC-MS

dc.subject

SARS-CoV-2

dc.subject

antigen presentation

dc.subject

dentritic cells

dc.subject

glycopeptides

dc.subject

glycoslyation

dc.subject

human leukocyte antigen

dc.subject

immunopeptidomics

dc.title

Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells.

dc.type

Journal article

duke.contributor.orcid

Saunders, Kevin|0000-0001-7399-7954

pubs.begin-page

109179

pubs.issue

8

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke Human Vaccine Institute

pubs.organisational-group

Surgery, Surgical Sciences

pubs.organisational-group

Duke

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Surgery

pubs.organisational-group

Clinical Science Departments

pubs.publication-status

Published

pubs.volume

35

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells.pdf
Size:
4.7 MB
Format:
Adobe Portable Document Format